BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

Browsing Tag

CalciMedica Inc. (NASDAQ:CALC)

2 posts

Biotech NewsCalciMedica (CALC): High-Risk Biotech or Deep-Science Sleeper?

  • BioTech Health X
  • January 18, 2026
The company was founded around a specific scientific insight: dysregulated calcium signaling plays a central role in severe…
0 Shares
0
0
0
0
0
0
0

Biotech NewsCalciMedica (CALC) Advances Phase 2 Trial for Acute Kidney Injury

  • BioTech Health X
  • November 25, 2025
CalciMedica Inc. (NASDAQ:CALC) is a clinical-stage biopharmaceutical company built on over a decade of pioneering research in calcium…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • Healthcare Stocks Sold Off Fast — But Molina Healthcare (MOH) May Be Misunderstood
  • HCA Healthcare (HCA) Is Acting Like a Defensive Growth Stock—and Analysts Agree
  • Wall Street Sees Nearly 15% Upside in McKesson Corporation (MCK)—Here’s Why
  • The IPO Everyone Missed: Why Medline (MDLN) Could Become the “Costco of Healthcare Supplies”
  • This Side of Healthcare Gets Paid No Matter What the Economy Does
Recent Comments
  • Novavax Announces Robust First Quarter 2024 Results and Strategic Partnerships • BioTech Health X on Novavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • January 31, 2026
    Healthcare Stocks Sold Off Fast — But Molina Healthcare (MOH) May Be Misunderstood
    • January 31, 2026
    HCA Healthcare (HCA) Is Acting Like a Defensive Growth Stock—and Analysts Agree
    • January 31, 2026
    Wall Street Sees Nearly 15% Upside in McKesson Corporation (MCK)—Here’s Why
    • January 30, 2026
    The IPO Everyone Missed: Why Medline (MDLN) Could Become the “Costco of Healthcare Supplies”
    • January 30, 2026
    This Side of Healthcare Gets Paid No Matter What the Economy Does
Recent Posts
  • Investors Keep Chasing Hype — But Healthcare’s Real Cash Machines Are Right Here
    • January 30, 2026
  • Here’s Why Healthcare Equipment and Services Keep Winning Even When Markets Panic
    • January 29, 2026
  • This Biotech Keeps Raising Red Flags — Why Coeptis Therapeutics (COEP) Looks More Like a Warning Than an Opportunity
    • January 28, 2026
Categories
  • BioTech CEO Interviews (9)
  • Biotech Info (5)
  • Biotech News (753)
  • Uncategorized (2)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top